Annovis Bio, Inc.
ANVS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001477845
No open-market purchases or sales by Annovis Bio, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $20.2M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Annovis Bio, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −8 vs. Q4 2021
- Shares held
- 889.6K
- −226.5K (−20.3%) vs. Q4 2021
- Total value
- $11.9M
- −$7.75M (−39.5%) vs. Q4 2021
- New holders
- 2
- 8 more added
- Sold out
- 10
- 7 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $20.2M |
| Q1 2026 | 56 | $10.5M |
| Q4 2025 | 53 | $14.7M |
| Q3 2025 | 42 | $4.19M |
| Q2 2025 | 42 | $3.93M |
| Q1 2025 | 44 | $3.13M |
| Q4 2024 | 40 | $7.93M |
| Q3 2024 | 35 | $9.50M |
| Q2 2024 | 31 | $5.67M |
| Q1 2024 | 31 | $14.3M |
| Q4 2023 | 36 | $22.5M |
| Q3 2023 | 30 | $10.6M |
| Q2 2023 | 28 | $18.3M |
| Q1 2023 | 23 | $11.6M |
| Q4 2022 | 23 | $9.93M |
| Q3 2022 | 25 | $10.0M |
| Q2 2022 | 26 | $8.73M |
| Q1 2022 | 24 | $11.9M |
| Q4 2021 | 32 | $19.6M |
| Q3 2021 | 38 | $36.2M |
| Q2 2021 | 57 | $109.0M |
| Q1 2021 | 31 | $23.1M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Annovis Bio, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 242,461 | $3.24M | 0.00% | +13,306+5.8% | Added |
| BlackRock Inc. | 147,693 | $1.97M | 0.00% | +94+0.1% | Added |
| Morgan Stanley | 110,058 | $1.47M | 0.00% | −44,923−29.0% | Reduced |
| Millennium Management LLC | 62,676 | $837.0K | 0.00% | −4,468−6.7% | Reduced |
| Two Sigma Advisers, LP | 46,400 | $619.0K | 0.00% | −17,400−27.3% | Reduced |
| Geode Capital Management, LLC | 42,027 | $561.0K | 0.00% | +1,082+2.6% | Added |
| Wescott Financial Advisory Group, LLC | 41,607 | $555.0K | 0.14% | 00.0% | Unchanged |
| Modera Wealth Management, LLC | 31,313 | $418.0K | 0.02% | −1,000−3.1% | Reduced |
| Bank of New York Mellon Corp | 25,525 | $340.0K | 0.00% | −5,378−17.4% | Reduced |
| Bridgeway Capital Management, LLC | 23,600 | $315.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 23,197 | $310.0K | 0.00% | +12,697+120.9% | Added |
| Sterling Investment Advisors, Ltd. | 18,974 | $253.0K | 0.07% | +4,500+31.1% | Added |
| State Street Corp | 17,135 | $229.0K | 0.00% | +735+4.5% | Added |
| Knoll Capital Management, LLC | 14,210 | $190.0K | 0.12% | 00.0% | Unchanged |
| Essex LLC | 11,593 | $155.0K | 0.04% | +1,000+9.4% | Added |
| Cannell Peter B & Co Inc | 10,000 | $134.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 8,777 | $117.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 7,168 | $96.0K | 0.00% | −4,983−41.0% | Reduced |
| Advisor Group Holdings, Inc. | 2,870 | $38.0K | 0.00% | −5,724−66.6% | Reduced |
| Rockefeller Capital Management L.P. | 1,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 600 | $8.00K | 0.01% | +600 | New |
| IFP Advisors, Inc | 600 | $6.00K | 0.00% | +600 | New |
| Citigroup Inc | 75 | $1.00K | 0.00% | +70+1,400.0% | Added |
| Financial Connections Group, Inc. | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −59,147−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −51,747−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −23,116−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −16,418−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,743−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,273−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,481−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −1,679−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −669−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −3−100.0% | Sold out |